Search Bar & Filters
Found 6 Actively Recruiting clinical trials
Actively Recruiting
This research aims to evaluate the long-term safety and tolerability of brivaracetam in children and adolescents with epilepsy, including those who participated in earlier studies or are newly enrolled in Japan with partial-onset seizures. The study also seeks to assess pharmacokinetic data in Japanese participants. The study is an open-label, single-arm, multicenter trial focusing on pediatric epilepsy treatment with brivaracetam. Participants will receive brivaracetam tablets or oral solution administered twice daily in two equal doses. Dosage varies based on weight up to 5 mgkgday for those weighing 11 to less than 20 kg, up to 4 mgkgday for those weighing 20 to less than 50 kg, and no more than 200 mgday. Directly enrolled participants in Japan will receive 1 to 4 mgkgday, not exceeding 200 mgday. The study includes long-term follow-up for up to 5 years. During the study, participants will be monitored for treatment-emergent adverse events, serious adverse events, and adverse events leading to discontinuation of the drug. Evaluations occur from Day 1 through safety visits over the 5-year period. Researchers will assess safety, tolerability, and pharmacokinetics. The total participation duration extends up to 5 years, with ongoing safety evaluations throughout this time.
Actively Recruiting
Healthy Volunteer
Researchers are investigating how moderate hypoxia, a condition where oxygen levels are reduced, affects brain activity in healthy adults. Although severe hypoxia is harmful, intermittent moderate hypoxia may benefit heart and metabolic health. This study aims to explore how continuous and intermittent moderate hypoxia influence resting brain dynamics using brain imaging and electrical activity measurements. Participants will undergo three sessions in a random order continuous moderate hypoxia for 30 minutes, intermittent moderate hypoxia with six cycles of 5 minutes hypoxia followed by 5 minutes normal oxygen, and a normoxia session with normal air for 30 minutes. During these sessions, participants wear a device that controls oxygen levels via a mask, targeting oxygen saturation between 85% and 90%. Brain activity is recorded simultaneously through EEG and near-infrared spectroscopy, while muscle activity is also monitored. Participants will have brain activity and blood oxygen changes measured throughout each session and on following days. Their corticospinal excitability will be assessed before and after each session using transcranial magnetic stimulation. The study involves three experimental visits spaced at least one week apart, with continuous monitoring of brain connectivity and excitability to better understand the effects of moderate hypoxia on brain health.
Actively Recruiting
Healthy Volunteer
Researchers are studying how new motor skills are learned from scratch by examining changes in the brains motor system excitability during motor learning sessions. This research focuses on understanding the brain plasticity mechanisms involved in learning new movements, particularly exploring increased corticospinal excitability and motor cortex reorganization. The study aims to measure these changes across three separate motor learning sessions spaced over time. Participants will engage in three de novo motor learning sessions on days 1, 2, and 9. During these sessions, they will perform specific motor tasks designed to evaluate learning progress and brain excitability changes. The study uses single-pulse and paired-pulse transcranial magnetic stimulation TMS to assess motor evoked potentials and intracortical inhibition and facilitation at various time points before and after each session. Throughout the study, participants will be assessed on motor evoked potential amplitude input-output curves and short-interval and long-interval intracortical inhibition as well as intracortical facilitation at baseline and immediately before and after each motor learning session. Motor learning performance will be measured using movement path length during a 3D finger-cursor task. The total involvement includes multiple assessments to track brain activity and motor skill acquisition over nine days.
Actively Recruiting
Researchers are studying how the timing of exercise and the type of exercise affect blood sugar control in adolescents aged 10 to 16 who have type 1 diabetes. This study evaluates the impact of exercising in the morning versus the afternoon and compares continuous moderate exercise with intense intermittent exercise. The goal is to better understand how these factors influence blood glucose levels during and after physical activity. Participants will perform four types of exercise tests using a cycloergometer continuous moderate exercise in the morning, continuous moderate exercise in the afternoon, intermittent intense exercise in the morning, and intermittent intense exercise in the afternoon. The study is randomized and controlled, with no masking. Each participant will experience these different exercise conditions to allow comparison of glycemic responses. Throughout the study, researchers will monitor blood glucose changes during and after each exercise session. They will compare glycemic variations between the four exercise conditions over a period extending to September 2026. Participants must comply with study procedures and attend all sessions, providing consent along with their legal guardians. The study includes assessments to ensure safety and proper adherence, aiming to gather detailed information on how exercise timing and type affect glycemic regulation in young people with type 1 diabetes.
Actively Recruiting
Healthy Volunteer
Researchers are investigating how a single session of moderate aerobic exercise affects motor cortex neuroplasticity in older adults and comparing these effects with those in young adults. The study focuses on understanding how exercise, alone and combined with transcranial direct current stimulation tDCS, influences brain changes related to motor function and sensorimotor integration, which may decline with age. This research aims to improve knowledge about strategies to preserve motor function and independence in aging populations. Participants will take part in three experimental sessions involving different conditions aerobic exercise followed by tDCS, physical inactivity followed by tDCS, and aerobic exercise alone. The aerobic exercise consists of 20 minutes of cycling on an ergometer at moderate intensity, while tDCS involves 20 minutes of anodal stimulation over the primary motor cortex. Sessions are spaced at least one week apart, with randomized order for the first two conditions. During each session, participants will undergo assessments using transcranial magnetic stimulation TMS to measure corticospinal excitability and intracortical and sensorimotor circuit functions before and after interventions. Researchers will record motor evoked potentials from a hand muscle to evaluate neuroplasticity changes. Additional evaluations include questionnaires on physical activity and pain. Each session lasts between about 1 to 2 hours, with careful monitoring of exercise intensity and brain responses to the interventions.
Actively Recruiting
Researchers are evaluating whether adding venetoclax to a chemotherapy treatment using fludarabine, cytarabine, and gemtuzumab ozogamicin can improve survival for children, adolescents, and young adults with acute myeloid leukemia AML who are in first relapse but cannot receive more anthracycline drugs, or those in second relapse. This randomized Phase 3 trial focuses on this patient group with a poor prognosis due to chemotherapy-resistant leukemia cells. Participants receive intensive chemotherapy over two 42-day cycles. In the experimental group, venetoclax is taken orally alongside chemotherapy for the first two cycles, and if clinical benefit is seen but transplant is not possible, maintenance treatment with venetoclax and azacitidine may continue for up to 24 cycles. The control group receives chemotherapy followed by azacitidine alone for maintenance therapy, also up to 24 cycles. Gemtuzumab ozogamicin is given to those whose leukemia cells express CD33. Participants are closely monitored with assessments after the two induction cycles to decide on stem cell transplantation or maintenance therapy. Researchers measure overall survival for up to 5 years, along with response rates, event-free survival, relapse rates, and treatment safety. Blood samples are taken to study venetoclax levels. The total study participation can last several years to track long-term outcomes and adverse events under the care of the study team.